Tuomas Kiviniemi
Tuomas Kiviniemi is an expert in Cardiology at Turku University Hospital (Finland). As of October 2026, ScienceLeadR ranks Tuomas Kiviniemi in the top 1% of experts worldwide for Atrial Fibrillation. Tuomas Kiviniemi has authored 213 publications, the most recent in 2026, and is an investigator in 22 clinical trials, 3 of them ongoing. SLR score: 859 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Neurosurgery - Biochemistry - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2003 - 2026
Number : 213
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
Clinical Studies 22
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
3 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A Study to Find Out How Safe and Effective AZD0780 Is for Adults with High Bad Cholesterol from an Inherited Condition 2025-520520-17-00 — cholesterol, ldl, lipoproteins, cholesterol, lipoproteins, ldl | Phase 3 | Active not recruiting | 2025 |
| Low Workload Concept for the Detection of Silent Atrial Fibrillation (AF) and Atrial Fibrillation Burden in Patients at High Risk of AF and Stroke NCT05351775 — mortality, heart diseases, hospitalization, stroke, heart, arrhythmias, cardiac, data collection, cardiovascular diseases, workload, atrial fibrillation, algorithms, cardiology, photoplethysmography, smartphone, mobile applications, diagnosis, research, beds, therapeutics, pathologic processes, electrocardiography, postoperative complications | N/A | Active not recruiting | 2022 |
| Drug Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI NCT04814212 — myocardial ischemia, stents, hemorrhage, drug-eluting stents, coronary artery disease, pharmaceutical preparations, percutaneous coronary intervention, acute coronary syndrome, arteries, coronary disease, ischemia | N/A | Recruiting | 2022 |
LeadR Networks
Main global connection map